Wall Street Zen Downgrades Nature’s Sunshine Products (NASDAQ:NATR) to Buy

Posted by George Bondi on Aug 10th, 2026

Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

Several other brokerages also recently weighed in on NATR. Canaccord Genuity Group reduced their price objective on shares of Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. DA Davidson raised shares of Nature’s Sunshine Products to a “strong-buy” rating in a research report on Monday, July 6th. Finally, Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $34.50.

View Our Latest Report on Nature’s Sunshine Products

Nature’s Sunshine Products Price Performance

Nature’s Sunshine Products stock opened at $16.38 on Friday. Nature’s Sunshine Products has a 1-year low of $12.97 and a 1-year high of $28.14. The stock has a market cap of $288.29 million, a PE ratio of 16.22 and a beta of 0.88. The stock’s fifty day moving average is $20.62 and its two-hundred day moving average is $23.50.

Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.06). Nature’s Sunshine Products had a net margin of 3.68% and a return on equity of 12.88%. The business had revenue of $116.99 million during the quarter, compared to analysts’ expectations of $123.70 million.

Insider Buying and Selling at Nature’s Sunshine Products

In related news, EVP Daniel C. Norman sold 9,713 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $20.64, for a total transaction of $200,476.32. Following the completion of the sale, the executive vice president owned 47,276 shares in the company, valued at $975,776.64. This represents a 17.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Bryant J. Yates sold 11,968 shares of Nature’s Sunshine Products stock in a transaction on Friday, June 5th. The shares were sold at an average price of $19.90, for a total transaction of $238,163.20. Following the completion of the transaction, the executive vice president owned 77,446 shares in the company, valued at approximately $1,541,175.40. This represents a 13.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 35,696 shares of company stock worth $742,407 in the last quarter. 3.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. State of Alaska Department of Revenue acquired a new stake in shares of Nature’s Sunshine Products during the fourth quarter worth $31,000. New York State Teachers Retirement System purchased a new position in Nature’s Sunshine Products during the 1st quarter worth $37,000. Raymond James Financial Inc. acquired a new stake in shares of Nature’s Sunshine Products in the 2nd quarter worth $37,000. Clearstead Advisors LLC boosted its holdings in shares of Nature’s Sunshine Products by 16,025.0% in the fourth quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock valued at $42,000 after acquiring an additional 1,923 shares in the last quarter. Finally, McIlrath & Eck LLC acquired a new position in shares of Nature’s Sunshine Products during the first quarter worth about $48,000. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Nature’s Sunshine Products

Here are the key news stories impacting Nature’s Sunshine Products this week:

Neutral Sentiment: Nature’s Sunshine appointed Ruth Perkins as executive vice president and chief financial officer, effective September 1, 2026. She will oversee the company’s global finance organization, including financial planning, accounting, treasury, tax, investor relations, and financial reporting. Nature’s Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
Neutral Sentiment: Management discussed the second-quarter performance and business outlook during its earnings call, providing additional context for the results and updated guidance. Nature’s Sunshine Products Q2 2026 Earnings Call Transcript
Negative Sentiment: Second-quarter adjusted earnings were $0.21 per share, below the $0.27 analyst consensus, while revenue of $116.99 million trailed expectations of $123.70 million. The earnings and sales shortfalls raised concerns about near-term profitability and demand. Nature’s Sunshine Reports Second Quarter 2026 Results
Negative Sentiment: The company lowered its full-year 2026 revenue outlook to $490 million–$500 million, below the analyst consensus of approximately $506.4 million. The reduced forecast likely reinforced investor concerns about slower growth. Nature’s Sunshine misses Q2 2026 sales expectations

About Nature’s Sunshine Products

(Get Free Report)

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.